Literature DB >> 31499196

Sex differences in the response to opioids for pain relief: A systematic review and meta-analysis.

Claudia Pisanu1, Flavia Franconi2, Gian Luigi Gessa3, Sergio Mameli4, Giovanni Maria Pisanu5, Ilaria Campesi6, Lorenzo Leggio7, Roberta Agabio8.   

Abstract

There are conflicting results about sex differences in the response to opioids for pain control and the role of potential influencing factors of these differences has not been investigated. We meta-analyzed differences and similarities between men and women in opioid response for pain control and investigated the potential influence of baseline pain intensity, age, body weight, and other factors in these findings. PubMed, Scopus, and Cochrane CENTRAL were searched through January 15, 2019, for clinical studies in which opioids were administered for pain control. We included clinical studies in which (a) opioids were used to treat acute or chronic pain, (b) the response to opioids was broken down for men and women, and (c) the response to opioids was reported as (i) difference between baseline and final Visual Analog Scale of Pain Intensity (VASPI) score 30 min after opioid administration (Delta-VASPI at 30'), or daily dose of opioids (ii) self-administered by patients (patient-controlled analgesia PCA), or (iii) administered by physicians. Risk of bias was evaluated using ROBINS-I and the overall quality of evidence for primary outcomes was evaluated using the GRADE system. Globally, we included 40 comparisons (6794 patients). Regarding acute pain, we found moderate quality of evidence that women and men do not differ in their response to opioids 30 min after their administration [Delta-VASPI at 30': mean difference, MD = 0.42 (-0.07; 0.91)]. We also found moderate quality of evidence that women self-administer lower daily amounts of opioids [daily PCA: standardized mean difference, SMD = -0.30 (-0.41; -0.18)]. Regarding chronic pain, we found low quality of evidence that women receive lower daily doses for non-cancer pain [MD = -36.42 (-57.86; -14.99)]. By contrast, we found very low quality of evidence that women and men do not differ in the daily dose of opioids for cancer pain [MD = -16.09 (-40.13; 7.94)]. Age, comorbid mental disorders, type of administration, type of opioids, type of patients, and body weight significantly modified these results. In conclusion, the results of the present meta-analysis suggest that men and women may differ in the response to opioids for pain relief, but these differences as well as similarities are significantly influenced by factors like age and comorbid mental disorders. However, the role of these factors is not usually evaluated in the prescription of opioids for pain control. There is an urgent need to conduct clinical trials on the use of opioid medications for pain, in which information about all possible influencing factors are provided and broken down for men and women.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute pain; Buprenorphine (PubChem CID: 644073); Chronic pain; Fentanyl (PubChem CID: 3345); Gender differences; Hydrocodone (PubChem CID: 5284569); Hydromorphone (PubChem CID: 5284570); Morphine (PubChem CID: 5288826); Nalbuphine (PubChem CID: 5311304); Opioids; Pentazocine (PubChem CID: 441278); Sex differences; Tramadol (PubChem CID: 33741); Women

Mesh:

Substances:

Year:  2019        PMID: 31499196     DOI: 10.1016/j.phrs.2019.104447

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  16 in total

Review 1.  Sex differences in opioid receptor mediated effects: Role of androgens.

Authors:  Jessica L Sharp; Tallia Pearson; Mark A Smith
Journal:  Neurosci Biobehav Rev       Date:  2022-01-04       Impact factor: 8.989

2.  Elevated customary alcohol consumption attenuates opioid effects.

Authors:  Monique M Cherrier; Danny D Shen; Laura Shireman; Andrew J Saxon; Tracy Simpson; Alex Men; Preetma Kooner; Gregory W Terman
Journal:  Pharmacol Biochem Behav       Date:  2021-11-04       Impact factor: 3.533

3.  Sex-specific role for serotonin 5-HT2A receptor in modulation of opioid-induced antinociception and reward in mice.

Authors:  Salvador Sierra; Karan H Muchhala; Donald K Jessup; Katherine M Contreras; Urjita H Shah; David L Stevens; Jennifer Jimenez; Xiomara K Cuno Lavilla; Mario de la Fuente Revenga; Kumiko M Lippold; Shanwei Shen; Justin L Poklis; Liya Y Qiao; William L Dewey; Hamid I Akbarali; M Imad Damaj; Javier González-Maeso
Journal:  Neuropharmacology       Date:  2022-02-17       Impact factor: 5.273

4.  Opioid-Induced Hyperalgesic Priming in Single Nociceptors.

Authors:  Eugen V Khomula; Dionéia Araldi; Ivan J M Bonet; Jon D Levine
Journal:  J Neurosci       Date:  2020-11-17       Impact factor: 6.167

5.  Sex- and Gender-Based Pharmacological Response to Drugs.

Authors:  Franck Mauvais-Jarvis; Heiner K Berthold; Ilaria Campesi; Juan-Jesus Carrero; Santosh Dakal; Flavia Franconi; Ioanna Gouni-Berthold; Mark L Heiman; Alexandra Kautzky-Willer; Sabra L Klein; Anne Murphy; Vera Regitz-Zagrosek; Karen Reue; Joshua B Rubin
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

6.  Predictive variables of prescription opioid misuse in patients with chronic noncancer pain. Development of a risk detection scale: A registered report protocol.

Authors:  Carmen Ramírez-Maestre; Alicia E López-Martínez; Rosa Esteve
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

7.  Pain Across the Menstrual Cycle: Considerations of Hydration.

Authors:  Beverly Tan; Michael Philipp; Stephen Hill; Ahmad Munir Che Muhamed; Toby Mündel
Journal:  Front Physiol       Date:  2020-10-08       Impact factor: 4.755

Review 8.  Sex-specific and gender-specific aspects in patient-reported outcomes.

Authors:  Caroline Hertler; Annina Seiler; Dorothee Gramatzki; Markus Schettle; David Blum
Journal:  ESMO Open       Date:  2020-11

9.  Codeine and Tramadol Use in Athletes: A Potential for Abuse.

Authors:  Thomas Zandonai; Mónica Escorial; Ana M Peiró
Journal:  Front Pharmacol       Date:  2021-06-10       Impact factor: 5.810

10.  Sex Differences in Associations Between CYP2D6 Phenotypes and Response to Opioid Analgesics.

Authors:  Guilherme S Lopes; Suzette J Bielinski; Ann M Moyer; John Logan Black Iii; Debra J Jacobson; Ruoxiang Jiang; Nicholas B Larson; Jennifer L St Sauver
Journal:  Pharmgenomics Pers Med       Date:  2020-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.